Upcoming Login Downtime
We're updating the Biocentury.com platform login experience to make access more secure and reliable. As part of this update, logins will be temporarily unavailable on Sunday, March 16, from 4:00AM to 4:00PM GMT. We recognize the inconvenience and appreciate your understanding. Please check back after the maintenance period.
For updates, questions, or issues, please call us at +1 650-552-4224 or email us at support@biocentury.com.
- Company Profiles
- Target Profiles
- Product Profiles
Explore BCIQ profiles by entering a target name.
BioCentury | Sep 17, 2022
Product Development
Sept. 16 Quick Takes: AZ’s danicopan meets in Phase III
Plus updates from Alnylam, Mallinckrodt, Neuron23-Qiagen and more
BioCentury | Nov 23, 2021
Product Development
Nov. 22 Quick Takes: GSK, Arrowhead in deal for NASH candidate
Plus Zenas-Xencor, BioCryst, Deciphera, bluebird, Exelixis and more
BioCentury | Nov 14, 2020
Emerging Company Profile
Ex-Mavupharma execs reunite at Inipharm to build liver disease pipeline
Emerging Company Profile: Inipharm will use its $35M series A to advance lead liver program through Phase I
Items per page:
1 - 5 of 5